Quadrant Laboratories is a wholly owned subsidiary of Quadrant Biosciences, a life sciences company dedicated to improving the lives of children and families by delivering innovative diagnostic, therapeutic, and virtual care solutions for global health priorities. Through the development of novel diagnostics, Quadrant Laboratories provides solutions that accelerate the diagnostic timeline and deliver scientifically sound results earlier allowing individuals to make informed healthcare decisions.
Our focus on early diagnosis in the fields of autism spectrum disorder, mild traumatic brain injury and Parkinson’s disease may change the course of a person’s life by allowing earlier access to treatment.
During the height of the COVID-19 pandemic, our work in developing the most sensitive COVID saliva test on the market gave millions of New Yorkers access to PCR testing, and our high throughput labs allowed for a quick turn-around of results.
Solutions and results to inform decisions
We have three distinct laboratories dedicated to providing solutions and results so you can make informed healthcare decisions.
Our Research and Development experts collaborate with top academic institutions, medical researchers and AI engineers to translate breakthrough findings into thoughtfully developed and scientifically sound molecular diagnostic tools.
Our high throughput CLIA/CLEP certified clinical lab processes patient samples using the latest, most cutting-edge laboratory technology to aid in not only diagnosis and treatment, but identifying underlying genetic causes of a diagnosis.
Our environmental lab monitors wastewater samples for the presence of SARS-CoV-2 from influent water sources. Regular surveillance and reporting informs clients of changes in infection rates allowing them to institute mitigation strategies.